Applications Published 19 May 2001
Published: 9-Feb-2002
The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT).
The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT).
Method to make snow for insect control and device for making same
Eliasson, Bertil; Hallberg, Per-Ake 1096851*Skin and tissue care and/or treatment agent
Mandorlo Investment 1096918*Systems and methods for local delivery of an agent
CR Bard 1096919*Scented oxygen
Messer Griesheim 1096920*Liposomal encapsulated nucleic acid-complexes
Inex Pharmaceuticals 1096921*Improved stable topical ascorbic acid compsns
Shaklee Corp 1096922*Blister containing a single transdermal therapeutic system and a single dose form of administration
LTS Lohmann Therapie-Systeme 1096923*Use of inhibitors of prenyltransferases for inhibiting fungal growth
Mitotix 1096925*Methods and compounds for treating depression
NPS Pharmaceuticals 1096926*Compsn for treatment of stress
Massachusetts Institute of Technology 1096927*New pharmaceutical preparation and method
A+ Science Invest 1096928*Therapeutic compsn based on flavonoids for use in the treatment of tumours with cytotoxic agents
Laboratoires L Lafon 1096929*Therapeutic compsn based on flavonoids for use in the treatment of tumours with cytotoxic agents
Laboratoires L Lafon 1096930*Use of (S)-(-)-amisulpride for the manufacture of a medicment for the treatment of schizophrenia
Sanofi-Synthelabo 1096931*Antihypertensive combination of valsartan and calcium channel blocker
Novartis 1096932*Use of an inhibitor of cytochrome P450 optionally combined with an antifungal agent for treating mycoses
Investigations Therapeutiques essais cliniques services 1096933*Oxazolidinones to treat eye infections
Pharmacia & Upjohn 1096934*Medicinal product and method for treatment and prevention of dyskinesia
A Carlsson Research 1096935*Treatment of dyskinesia
The Victoria University of Manchester 1096936*Sustained release ranolazine formulations
CV Therapeutics 1096937*Anti-irritant compsns containing a cyclic 2'-deoxy-nucleotide
E-L Management 1096938*Nocathiacin antibiotics
Bristol-Myers Squibb 1096939*Biocompatible and biodegradable compsns containing hyaluronic acid and the derivatives thereof for the treatment of ulcers in the digestive system
Fidia Advanced Biopolymers 1096940*Bone marrow cells as a source of neurons for brain and spinal cord repair
University of South Florida 1096941*Use of a medicine containing a quantity of tyrothricine for the treatment of viral infections
Karl Engelhard Fabrik 1096942*Method of preparation and pharmaceutical compsn of an Uncaria water soluble extract
Pero, Ronald 1096943*Extracts of Zanthoxylum bungeanum, pharmaceutical and cosmetic formulations containing them
Indena 1096944*Lysine binding fragments of angiostatin
Bristol-Myers Squibb 1096945*Delta cleavage products and methods based thereon
Yale University 1096946*Topical drug for the treatment of viral infections
Karl Engelhard Fabrik 1096947*Use of Interleukin-11 to treat gastrointestinal disorders
Genetics Institute 1096948*Treatment of celiac disease with interleukin-15 antagonists
The Mathilda and Terence Kennedy Institute of Rheumatology 1096949*Therapies using hemoproteins
Duke University Medical Centre 1096950*Use of bromelain proteases for inhibiting blood coagulation
Ursapharm Arzneimittel 1096951*Polysaccharide vaccine for staphylococcal infections
The Brigham and Women's Hospital 1096952*Use of inactivated immunosuppressive and/or angiogenic, immunogenic proteins, preparation method and pharmaceutical or vaccine uses
Vacs International 1096953*Adjuvant and vaccine compsns containing monophosphoryl lipid A
American Cyanamid 1096954*Cancer treatment method using antibodies to aminophospholipids
Board of Regents, the University of Texas System 1096955*Intracellular sensitisers for sonodynamic therapy
Pharmacyclics 1096956*Methods and reagents for intramuscular delivery of nucleic acids
Johns Hopkins University School of Medicine 1096957*Crystalline salts of dodecyl-2-(N, N-) dimethylamino)-propionate
Nexmed Holdings 1097126*Diacylhydrazine derivatives as integrin inhibitors
Merck 1097127*Imidamide derivatives
Bayer 1097128*N-benzocycloalkyl-amide derivatives and their use as medicaments
Novartis 1097129*Method for preparing hydroxymethylthiobutyric acid
Aventis Animal Nutrition 1097130*Method for separating hydroxymethylthiobutyric acid
Aventis Animal Nutrition 1097131*Functional vitamin D derivatives and a method for determining 25-hydroxy-vitamin D and 1-alpha,25-dihydroxy-vitamin D
Immunodiagnostik Gesellschaft fuer Produktion und Vertrieb von Labordiagnostika 1097132*Method for preparing vitamin A
Aventis Animal Nutrition 1097133*Arylpiperazine derivatives useful as uroselective alpha1-adrenaoceptor blockers
Ranbaxy Laboratories 1097134*Process for the preparation of an indole derivative
SmithKline Beecham 1097135*Process for the preparation of an indole derivative
SmithKline Beecham 1097136*N-substituted naphthalene carboxyamides a neurokinin-receptor antagonists
AstraZeneca 1097137*Pharmaceutical compsns containing 2-quinolones
Laboratoire L Lafon 1097138*Quinoline derivatives
Active Biotech 1097139*Biphenylsulphonyl-substituted imidazole derivatives, their preparation process, their use as a drug or diagnostic, and drug containing them
Aventis Pharma Dutschland 1097140*azole derivatives with biphenyl-sulphonyl substitution, method of preparing them and their use as a drug or diagnostic agent
Aventis Pharma Deutschland 1097141*Phthalazine derivatives phosphodiesterase 4 inhibitors
Zambon Group 1097142*Method for preparing 4,6-disubstituted 2-isocyanatopyrimidines and to their use as intermediate products for active ingredient syntheses
Aventis Pharma Deutschland 1097144*Polyhydroxyalkylpyridine derivatives and their preparation and medicines containing them
Aventis Pharma 1097145*Method for producing 2-amino-4-chloro-1,3,5-triazines
Aventis CropScience 1097146* Novel angiogenesis inhibitors
Merck 1097147* Polymorph of ritonavir
Abbott Laboratories 1097148*Bicyclohexane derivatives
Eli Lilly 1097149*Imidazolyl
derivatives 1097150*Improved process for synthesising carbapenem intermediates
Merck 1097151*Synethesis of compounds useful in the manufacture of ketorolac
Mallinckrodt 1097152*Novel triazolo(4,5-D)pyrimidine compounds
AstraZeneca 1097153*Substituted benzimidazioles, production and use thereof as agents for combating parasitic protozoas
Bayer 1097154*Photochromic six-membered heterocyclic-fused naphthopyrans
Transitions Optical 1097155*Photochromic benzopyrano-fused naphthopyrans
Transitions Optical 1097156*Organometallic compsns
ICI 1097157*Ligands for metal and metal-catalysed processes
Massachusetts Institute of Technology 1097158*Phosphinous and phosphonic acid derivatives used as medicaments
Aventis Pharma Deutschland 1097159*Preparation and use of alpha-keto bisphosponates
University of Southern California 1097160*Oligonucleotides having site specific chiral phosphorothioate internucleside linkages
Isis Pharmaceuticals 1097162*Improved glycosylation method using sulphoxide donors
Princeton University 1097163*Process for coupling amino acids using bis-(trichloromethyl) carbonate
Peptor 1097164*Novel inhibitors of angiogenesis and tumour growth
Gill, Parkash 1097165*Potassium channel polypeptide and polynucleotide compsns
Elan Pharmaceuticals 1097166*Neurotrophic growth factor
Janssen Pharmaceutica 1097167*Compounds and methods for modulating cadherin-mediated functions
Adherex Technologies 1097168*Mouse growth hormone secreatgogue receptor
Merck 1097169*Growth hormone secretagogue related receptors and nucleic acids
Merck 1097170*Method for purifying haemoglobin
Biopure Corp 1097171*Anti hepatitis C virus antibody and uses thereof
Connex Gesellschaft zur Optimierung von Forschung und Entwicklung 1097172*Peptides of of IL-2 and derivatives thereof and their use as therapeutic agents
Institut Pasteur 1097173*Lupus anticoagulant antibody to F1 region of prothrombin.
Gradipore 1097174*
